EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway

Jiaqian He, Yinzhi Kong, Yunyong Wang, Qiaoling Fang, Hemeng Wu, Kewei Du, Yuzhen Luo, Jinna Tan, Hui Yin, Hongsheng Lin iD, Mingfen Li iD

Journal of Hepatocellular Carcinoma · 2026-05 · Volume 13 · 1-15

DOI: 10.2147/jhc.s581550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-05. Verfasst von Jiaqian He und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GRB2PI3K/AKT pathwaydrug sensitivityhepatocellular carcinomahypoxiasorafenib

Autor:innen und Institutionen

  • The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, People's Republic of China.
  • Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine, Nanning, People's Republic of China.
  • Laboratory Department, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, People's Republic of China.
  • Laboratory Department, First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, People's Republic of China.

ORCID-Profile: Hongsheng Lin, Mingfen Li

Zitieren

APA

He, J., Kong, Y., Wang, Y., Fang, Q., Wu, H., Du, K., Luo, Y., Tan, J., Yin, H., Lin, H., & Li, M. (2026). GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s581550

Vancouver

He J, Kong Y, Wang Y, Fang Q, Wu H, Du K, et al. GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s581550

BibTeX
@article{He2026,
  author = {He, Jiaqian and Kong, Yinzhi and Wang, Yunyong and Fang, Qiaoling and Wu, Hemeng and Du, Kewei and Luo, Yuzhen and Tan, Jinna and Yin, Hui and Lin, Hongsheng and Li, Mingfen},
  title = {GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--15},
  doi = {10.2147/jhc.s581550}
}
Kostenlos starten →